Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy
Diabetic cardiomyopathy (DMCM) is the leading cause of mortality and morbidity among diabetic patients. DMCM is characterized by an increase in oxidative stress with systemic inflammation that leads to cardiac fibrosis, ultimately causing diastolic and systolic dysfunction. Even though DMCM pathophy...
Main Authors: | Amit K. Rai, Brooke Lee, Ramesh Gomez, Deepu Rajendran, Mahmood Khan, Venkata Naga Srikanth Garikipati |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2020.612722/full |
Similar Items
-
MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin
by: Beibei Dai, et al.
Published: (2018-09-01) -
Expression Profiling of Circular RNAs and Micrornas in Heart Tissue of Mice with Alcoholic Cardiomyopathy
by: Yuqiao Yang, et al.
Published: (2018-05-01) -
Elucidating the Functions of Non-Coding RNAs from the Perspective of RNA Modifications
by: Venkata Naga Srikanth Garikipati, et al.
Published: (2021-05-01) -
Pathophysiology and Clinical Utility of Non-coding RNAs in Epilepsy
by: Yiye Shao, et al.
Published: (2017-08-01) -
The Role of Non-coding RNAs in Viral Myocarditis
by: Cong Zhang, et al.
Published: (2020-07-01)